Skip to main content
. 2019 May 9;294(25):9844–9857. doi: 10.1074/jbc.RA119.007655

Figure 7.

Figure 7.

USP9X in Wnt/β-catenin signaling and breast carcinogenesis. The protein deubiquitinase USP9X interacts with BCL9 and acts to remove Lys-63–linked polyubiquitin on lysine 212 of BCL9. Then, USP9X-targeted BCL9 deubiquitination facilitates the formation of the β-catenin/BCL9/PYGO complex, thereby potentiating the transcriptional activation of Wnt/β-catenin target genes and promoting the proliferation and invasion of breast cancer cells.